Compare GRND & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GRND | TMDX |
|---|---|---|
| Founded | 2009 | 1998 |
| Country | United States | United States |
| Employees | 148 | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.5B |
| IPO Year | N/A | 2019 |
| Metric | GRND | TMDX |
|---|---|---|
| Price | $11.30 | $74.43 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $18.80 | ★ $148.22 |
| AVG Volume (30 Days) | ★ 1.5M | 1.3M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $605,494,000.00 |
| Revenue This Year | $23.08 | $24.25 |
| Revenue Next Year | $17.04 | $18.75 |
| P/E Ratio | ★ N/A | $371.45 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $9.79 | $60.11 |
| 52 Week High | $23.54 | $156.00 |
| Indicator | GRND | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 37.09 | 48.93 |
| Support Level | $10.76 | $64.90 |
| Resistance Level | $11.85 | $120.60 |
| Average True Range (ATR) | 0.51 | 3.91 |
| MACD | -0.22 | 2.21 |
| Stochastic Oscillator | 33.11 | 92.52 |
Grindr Inc is a social networking app for gay, bi, trans, and queer people. It is a social network that brings together gay and bisexual men who want to meet other men close to them in a completely discreet and anonymous way, without having to give any personal information or having to fill out a profile with confidential information in order to register.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.